CLINICAL_TRIALS trial_result · 2020-11-23

Clinical Trial Update: Downmodulating Monocyte Activation for HIV-1 Associated Neurocognitive Disorders (HAND) [Phase 4]

Phase 4 trial update on downmodulating monocyte activation for HIV-associated neurocognitive disorders has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: University of Pennsylvania | Conditions: HIV Dementia | Phase 4 | Status: COMPLETED | Results posted: 2020-11-23